Company
Headquarters: Cincinnati, OH, United States
Founded: 1992
Employees: 4,500
CEO: Dr. August James Troendle M.D.
$16.08 Billion
USD as of Jan. 1, 2026
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $222.61 B |
| Danaher | $164.98 B |
| Siemens Healthineers AG | $57.84 B |
| IDEXX Laboratories, Inc. | $53.62 B |
| Lonza Group Ltd | $47.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
| Last Financial Reports Date | Sept. 30, 2025 |
| Revenue TTM | $2.36 B |
| EBITDA | $535.5 M |
| Gross Profit TTM | $1.64 B |
| Profit Margin | 18.36% |
| Operating Margin | 21.49% |
| Quarterly Revenue Growth | 23.70% |
Medpace Holdings, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MEDP wb_incandescent
Stock: BMV: MEDP wb_incandescent
Stock: FSX: 01P wb_incandescent
Support services for pharmaceutical and medical device
Dr. August J. Troendle, President and CEO